Genelux Says FDA Grants Fast Track Designation For Olvi-Vec To Treat Ovarian Cancer

RTTNews | 667 days ago
Genelux Says FDA Grants Fast Track Designation For Olvi-Vec To Treat Ovarian Cancer

(RTTNews) - Immuno-oncology company Genelux Corp. (GNLX) announced Monday that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the development program of Olvi-Vec (olvimulogene nanivacirepvec) for the treatment of patients with platinum resistant/refractory ovarian cancer.

The company said the Fast Track designation granted for Olvi-Vec underscores its potential to address unmet medical needs in ovarian cancer.

Genelux is currently conducting OnPrime/GOG-3076, a Phase 3 multi-center, randomized, open-label registrational trial evaluating the efficacy and safety of Olvi-Vec in combination with platinum-based chemotherapy in patients with platinum-resistant/refractory ovarian cancer.

read more
Genelux Appoints Lourie Zak As New CFO

Genelux Appoints Lourie Zak As New CFO

Immuno-oncology company Genelux Corp. (GNLX) announced Monday that Lourie Zak will join the company as Chief Financial Officer, effective August 28, 2023.
RTTNews | 758 days ago
Sensex, Nifty Extend Declines For Fourth Day

Sensex, Nifty Extend Declines For Fourth Day

Indian shares ended lower for a fourth day running on Wednesday, with trade-related concerns, rising oil prices and continued selling by foreign investors keeping investors on edge.
RTTNews | 47 minutes ago
German Ifo Business Confidence At 4-Month Low

German Ifo Business Confidence At 4-Month Low

German business sentiment weakened to a four-month low in September as prospects of an economic recovery suffered a setback, monthly survey results from the Munich-based ifo Institute showed Wednesday. The business climate index fell unexpectedly to 87.7 in September from 88.9 in the previous month. The score was seen at 89.3.
RTTNews | 1h 6min ago